Swiss National Bank’s Acorda Therapeutics, Inc. ACOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-738
| Closed | -$254K | – | 2550 |
|
|
2019
Q3 | $254K | Hold |
738
| – | – | ﹤0.01% | 2476 |
|
|
2019
Q2 | $680K | Buy |
738
+160
| +28% | +$147K | ﹤0.01% | 2309 |
|
|
2019
Q1 | $921K | Buy |
578
+18
| +3% | +$28.7K | ﹤0.01% | 2107 |
|
|
2018
Q4 | $1.05M | Buy |
560
+17
| +3% | +$31.8K | ﹤0.01% | 1982 |
|
|
2018
Q3 | $1.28M | Hold |
543
| – | – | ﹤0.01% | 2003 |
|
|
2018
Q2 | $1.87M | Sell |
543
-145
| -21% | -$499K | ﹤0.01% | 1753 |
|
|
2018
Q1 | $1.95M | Hold |
688
| – | – | ﹤0.01% | 1648 |
|
|
2017
Q4 | $1.77M | Buy |
688
+53
| +8% | +$136K | ﹤0.01% | 1718 |
|
|
2017
Q3 | $1.8M | Hold |
635
| – | – | ﹤0.01% | 1687 |
|
|
2017
Q2 | $1.5M | Hold |
635
| – | – | ﹤0.01% | 1772 |
|
|
2017
Q1 | $1.6M | Hold |
635
| – | – | ﹤0.01% | 1715 |
|
|
2016
Q4 | $1.43M | Hold |
635
| – | – | ﹤0.01% | 1794 |
|
|
2016
Q3 | $1.59M | Sell |
635
-20
| -3% | -$50.1K | ﹤0.01% | 1661 |
|
|
2016
Q2 | $2.01M | Buy |
655
+32
| +5% | +$98K | ﹤0.01% | 1503 |
|
|
2016
Q1 | $1.91M | Buy |
623
+121
| +24% | +$371K | ﹤0.01% | 1478 |
|
|
2015
Q4 | $2.58M | Hold |
502
| – | – | 0.01% | 1163 |
|
|
2015
Q3 | $1.6M | Buy |
502
+61
| +14% | +$194K | ﹤0.01% | 1453 |
|
|
2015
Q2 | $1.76M | Buy |
441
+67
| +18% | +$268K | ﹤0.01% | 1398 |
|
|
2015
Q1 | $1.49M | Buy |
374
+6
| +2% | +$24K | ﹤0.01% | 1503 |
|
|
2014
Q4 | $1.81M | Buy |
368
+9
| +3% | +$44.2K | 0.01% | 1328 |
|
|
2014
Q3 | $1.46M | Sell |
359
-6
| -2% | -$24.4K | 0.01% | 1414 |
|
|
2014
Q2 | $1.48M | Hold |
365
| – | – | 0.01% | 1470 |
|
|
2014
Q1 | $1.66M | Buy |
365
+86
| +31% | +$391K | 0.01% | 1330 |
|
|
2013
Q4 | $978K | Hold |
279
| – | – | ﹤0.01% | 1520 |
|
|
2013
Q3 | $1.15M | Sell |
279
-14
| -5% | -$57.6K | ﹤0.01% | 1361 |
|
|
2013
Q2 | $1.16M | Buy |
+293
| New | +$1.16M | 0.01% | 1322 |
|